Conferences

News & Press

Fabric Genomics is a software genomics company that provides end-to-end genomic data analysis, annotation, curation, classification, and reporting solutions to clinical labs, hospital labs, life science companies, country sequencing programs, and research institutions. The organization’s machine-learning technologies and advanced proprietary algorithms VAAST and Phevor enable scientists to quickly and accurately process and analyze whole genomes, …

Read More

Intermountain Healthcare is starting to offer genetic testing to patients who have a history of cancer in their family to identify those who have hereditary cancer gene mutations and to determine appropriate treatment options. Intermountain’s bioinformatics team will work with vendor Fabric Genomics to help generate clinical reports that physicians will review to help counsel …

Read More

This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomics will announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to clinical labs. The offering enables therapy matching for cancer patients, giving clinicians targeted treatment choices for cancer patients. Now clinical labs have one integrated platform for the interpretation …

Read More

Fabric Genomics has partnered with Genomics England’s 100,000 Genomes Project, Rady Children’s Institute for Genomic Medicine (RCIGM), and The Utah Genome Project (UGP), to provide fast and accurate identification of pediatric disease-causing variants to improve the clinical care of children. Fabric Genomics’ Opal™ Clinical is the only genomic interpretation and reporting platform to include the algorithms VAAST and Phevor, two pioneering …

Read More

Today at the American Society for Human Genetics (ASHG) Annual Meeting, Edico Genome and Fabric Genomicsannounced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data. Through this partnership, users can seamlessly utilize Edico Genome’s DRAGENTM Bio-IT platform with Fabric Genomics’ Opal™ Clinical variant interpretation platform to accurately gain biological insights into both …

Read More

Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data analysis and annotation in collaboration …

Read More

Fabric Genomics and TOMA Biosciences announced a partnership in April to develop an end-to-end genomic testing and clinical interpretation product for somatic cancers. The new system integrates TOMA’s oligo selective sequencing (OS-Seq) technology, which was developed at Stanford University, and combines it with Fabric Genomics’ bioinformatics platform. “What TOMA does is a very specialized assay …

Read More